Supplier
Urgent Medical Clinic INC
Urgent Medical Clinic INC was paid $2.57M by Medicaid between Jan 2018 and Aug 2024, across 71 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.
33Billing provider infoURGENT MEDICAL CLINIC INC
SOUTHAVEN, MS 38671
SOUTHAVEN, MS 38671
33aNPI1578613188assigned 01/12/2007
33bProvider typeNon-Pharmacy Dispensing Site
28Total paid$2.57M
24GClaims119,418
24DCodes billed71
24AFirst – last monthJan 2018 – Aug 2024
Compared with peers
Next to other Non-Pharmacy Dispensing Site providers in Mississippi
Rank by total paid#2 of 5
Median peer was paid$282K
This provider vs. median9.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,862 | $556K | |
| 2019 | 26,835 | $518K | |
| 2020 | 16,875 | $361K | |
| 2021 | 15,475 | $458K | |
| 2022 | 13,569 | $337K | |
| 2023 | 9,620 | $242K | |
| 2024incomplete | 4,182 | $97K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32% | 13,384 | 11,483 | $813K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 8,509 | 7,352 | $375K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11% | 4,205 | 3,708 | $289K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 10% | 2,942 | 2,484 | $264K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 6.6% | 5,618 | 4,867 | $170K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3.1% | 1,824 | 1,534 | $79K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.9% | 6,752 | 3,157 | $75K |
| 99051 | 2.7% | 4,913 | 4,386 | $70K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.4% | 2,025 | 1,674 | $62K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.4% | 2,100 | 1,856 | $61K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.1% | 5,364 | 4,730 | $55K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.1% | 4,588 | 3,751 | $53K |
59 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 7,741 | $45K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.2% | 400 | $31K |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,425 | $15K |
| 99487 | Ccm add 20min | <1% | 945 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 349 | $13K |
| 81003 | <1% | 8,130 | $12K | |
| 81025 | <1% | 2,000 | $10K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 439 | $6K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,383 | $6K |
| 80053 | Comprehensive metabolic panel | <1% | 834 | $5K |
| 92551 | <1% | 958 | $5K | |
| 86308 | <1% | 940 | $4K | |
| 80061 | Lipid panel | <1% | 499 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 56 | $4K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 269 | $3K |
| 82962 | <1% | 1,481 | $3K | |
| 90686 | <1% | 210 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 247 | $2K |
| 99173 | <1% | 924 | $2K | |
| 87210 | <1% | 446 | $2K | |
| 99384 | <1% | 17 | $1K | |
| 87220 | <1% | 423 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 221 | $1K |
| 99490 | Ccm add 20min | <1% | 197 | $1K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 12 | $1K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 334 | $1K |
| 82947 | <1% | 421 | $1K | |
| 93000 | <1% | 92 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 93 | $946.40 |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 13 | $906.35 |
| 3008F | <1% | 618 | $860.98 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,732 | $590.85 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 409 | $557.10 |
| 99443 | <1% | 29 | $500.97 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 207 | $223.87 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 33 | $160.09 |
| 1160F | <1% | 212 | $151.48 | |
| 1159F | <1% | 212 | $151.47 | |
| 86318 | <1% | 13 | $143.83 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 14 | $136.45 |
| 1125F | <1% | 14 | $80.00 | |
| 99489 | Ccm add 20min | <1% | 372 | $77.84 |
| 3077F | <1% | 375 | $70.00 | |
| 3074F | <1% | 334 | $50.00 | |
| 3078F | <1% | 374 | $50.00 | |
| 3080F | <1% | 331 | $20.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 6,810 | $10.34 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 98 | $1.08 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 1,468 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 656 | $0.00 |
| 1036F | 0% | 2,383 | $0.00 | |
| 3079F | 0% | 89 | $0.00 | |
| 3044F | 0% | 15 | $0.00 | |
| 3075F | 0% | 13 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 238 | $0.00 |
| 4004F | 0% | 205 | $0.00 | |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 34 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 67 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 340 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHARMA, ACHIN (PHYSICIAN)